Brachytherapy Results for Low- and Intermediate-risk Prostate Cancer Treated at Mayo Clinic

According to a retrospective study published this month in the journal Brachytherapy,  permanent low-dose-rate (LDR)  prostate brachytherapy monotherapy with I-125 has worked well for men with low-and intermediate-risk prostate cancer.

Investigating outcomes for a series of 974 patients treated at the Mayo with this type of permanent “seed” implant brachytherapy¬† analysts focused on factors associated with biochemical failure and survival. Continue reading “Brachytherapy Results for Low- and Intermediate-risk Prostate Cancer Treated at Mayo Clinic”